1. "Gastrointestinal Oncology Service"
Formats
  1. Journal Article (2302)
  2. Meeting Abstract (1841)
  3. Review (139)
  4. Book Section (123)
  5. Editorial (93)
  6. Guidelines (36)
  7. Correspondence (33)
  8. Conference Paper (23)
  9. Miscellaneous (21)
  10. Research Letter (17)
  11. Book Whole (12)
Groups
  1. Gastrointestinal Oncology Service (4640)
  2. Solid Tumor Oncology Division (4640)
  3. Department of Medicine (4638)
  4. Center for Pancreatic Cancer Research (2270)
  5. Surgery (1040)
  6. Survivorship Research (992)

More Groups

People
  1. Leonard Saltz (790)
  2. Eileen O'Reilly (780)
  3. Ghassan Abou-Alfa (568)
  4. Nancy Kemeny (543)
  5. David Kelsen (537)
  6. David Ilson (433)

More People

Years
  1. 2025 (118)
  2. 2024 (307)
  3. 2023 (362)
  4. 2022 (346)
  5. 2021 (345)
  6. 2020 (326)

More Years

Publications
  1. Journal of Clinical Oncology (1276)
  2. Annals of Oncology (320)
  3. Annals of Surgical Oncology (140)
  4. Cancer (127)
  5. Clinical Cancer Research (107)
  6. Cancer Research (94)

More Publications

Publishers
  1. American Society of Clinical Oncology (1355)
  2. Oxford University Press (447)
  3. Elsevier Inc. (404)
  4. Springer (310)
  5. American Association for Cancer Research (279)
  6. Wiley Blackwell (239)

More Publishers

Results (4640)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • A pilot study of gemcitabine, nab-paclitaxel, PEGPH20 (PAG) and rivaroxaban for advanced pancreatic adenocarcinoma: Interim safety and efficacy analysis
    Meeting Abstract

    Yu, K.; Mantha, S.; Tjan, C.; Kaufmann, E.; Brenner, R. B.; Lowery, M.; Ku, G.; Raj, N.; Shcherba, M.; Goldberg, Z.; more...
    Annals of Oncology (2018)

    Fulltext@MSK | Save
  • Comparing metastatic (M) young onset (YO) colorectal cancer (CRC) with average onset (AO): Do they differ clinically and genetically?
    Meeting Abstract

    Dos Santos Fernandes, G.; Chatila, W.; Yaeger, R.; Mendelsohn, R.; Stadler, Z.; Segal, N. H.; Varghese, A.; Reidy, D.; Diaz, L.; Shia, J.; more...
    Annals of Oncology (2018)

    Fulltext@MSK | Save
  • Outcomes by prior transarterial chemoembolization (TACE) in the phase III CELESTIAL trial of cabozantinib (C) versus placebo (P) in patients (pts) with advanced hepatocellular carcinoma (HCC)
    Meeting Abstract

    Yau, T.; Cheng, A. L.; Meyer, T.; Ryoo, B. Y.; Park, J. W.; Klümpen, H. J.; Lim, H. Y.; Kim, S.; Knox, J.; Patel, M.; more...
    Annals of Oncology (2018)

    Fulltext@MSK | Save
  • Characterization of PD-L1, CD8, CD3, CD68 and PanCK in tumor microenvironment of Gl tract tumors with respect to patients' mismatch repair status and anti-PD-1 treatment outcome using 5Plex IHC and whole slide image analysis
    Meeting Abstract

    Zhang, W.; Khojasteh, M.; Hubbard, A.; Martin, J.; Wang, X.; Kamthamraju, S.; Munoz-Rodriguez, J. L.; Jiang, D.; Cai, Z.; Li, J.; more...
    Annals of Oncology (2018)

    Fulltext@MSK | Save
  • Activity & safety of spartalizumab (PDR001) in patients (pts) with advanced neuroendocrine tumors (NET) of pancreatic (Pan), gastrointestinal (GI), or thoracic (T) origin, & gastroenteropancreatic neuroendocrine carcinoma (GEP NEC) who have progressed on prior treatment (Tx)
    Meeting Abstract

    Yao, J. C.; Strosberg, J.; Fazio, N.; Pavel, M. E.; Ruszniewski, P.; Bergsland, E.; Li, D.; Tafuto, S.; Raj, N.; Campana, D.; more...
    Annals of Oncology (2018)

    Fulltext@MSK | Save
  • PD-L1 expression and T-cell inflamed gene expression profile (GEP) in Korean and US patients (pts) with advanced gastric cancer (GC)
    Meeting Abstract

    Rha, S. Y.; Ku, G. Y.; Kim, H. S.; Chung, H. C.; Amlashi, F. G.; Maru, D. M.; Fein, C.; Tang, L.; Savage, M. J.; Zhou, W.; more...
    Annals of Oncology (2018)

    Fulltext@MSK | Save
  • Prospective validation of prognostic scores to improve patient selection for immuno-oncology trials
    Meeting Abstract

    Massard, C.; Segal, N. H.; Cho, D. C.; Papadimitrakopoulou, V. A.; Rizvi, N. A.; Cho, B. C.; Yu, L.; Yang, H.; Hsieh, H. J.; Zhang, J.; more...
    Annals of Oncology (2018)

    Fulltext@MSK | Save
  • Outcomes by baseline alpha-fetoprotein (AFP) levels in the phase III CELESTIAL trial of cabozantinib (C) versus placebo (P) in previously treated advanced hepatocellular carcinoma (HCC)
    Meeting Abstract

    Kelley, R. K.; El-Khoueiry, A. B.; Meyer, T.; Rimassa, L.; Merle, P.; Chan, S. L.; Tran, A.; Parnis, F.; Tam, V. C.; Cattan, S.; more...
    Annals of Oncology (2018)

    Fulltext@MSK | Save
  • Causal modeling of CALGB/SWOG 80405 (Alliance) identifies primary (1°) side-related angiogenic drivers of metastatic colorectal cancer (mCRC)
    Meeting Abstract

    Das, R. K.; Furchtgott, L.; Ou, F. S.; Swanson, D.; Hayete, B.; Harms, B.; Cunha, D.; Latourelle, J.; Wuest, D.; Khalil, I.; more...
    Annals of Oncology (2018)

    Fulltext@MSK | Save
  • Mismatch repair deficient rectal cancer is resistant to induction combination chemotherapy
    Meeting Abstract

    Cercek, A.; Dos Santos Fernandes, G.; Roxburgh, C.; Ng, S.; Yaeger, R.; Segal, N.; Ganesh, K.; Reidy, D.; Smith, J. J.; Nash, G.; more...
    Annals of Oncology (2018)

    Fulltext@MSK | Save